3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neuroblastoma
4
Central Nervous System Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Ovarian Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Lung Neoplasms
2
Leukemia
2
Hodgkin Disease
2
Brain Neoplasms
2
Teratoma
1
Seminoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Germ Cell Cancer
1
Nonseminomatous germ cell tumor
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Malignant mesenchymal tumor
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Interventions
Etoposide
3
Cisplatin
3
Bleomycin
3
Carboplatin
2
sodium thiosulfate
1
etoposide phosphate
1
Vinblastine
1
Taxes
1
Surgical Procedures, Operative
1
Restraint, Physical
1
Paclitaxel
1
Ifosfamide
1
Cyproheptadine
1
Congresses as Topic
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Ovarian Germ Cell Cancer
×
etoposide phosphate
×
Clear all
NCT02429687
2023-04-25
MOGCT-01
Shandong University
Phase 3
Recruiting
129 enrolled